Does an enlarged spleen change the outlook for low platelet patients?

NCT ID NCT07182760

Not yet recruiting Knowledge-focused Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will look at 100 adults with low platelet counts to see how many have an enlarged spleen and whether that affects their symptoms, complications, or response to treatment. The goal is to better understand the role of the spleen in these blood disorders. No new treatments are being tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMEGAKARYOCYTIC APLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune thrombocytopenic purpura congenital amegakaryocytic thrombocytopenia lymphoproliferative syndrome myelodysplastic syndrome with single lineage dysplasia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AMEGAKARYOCYTIC APLASIA AUTOIMMUNE DISEASES WITH SECONDARY ITP LYMPHOPROLIFERATIVE DISORDER WITH SECONDARY ITP PRIMARY IMMUNE THROMBOCYTOPENIC PURPURA UNILINEAGE MYELODYSPLASTIC SYNDROME ( MEGAKARYOCYTE DYSPLASIA)

More trials for these conditions

Other studies related to the condition(s) this trial covers.